| In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs Z Gagic, D Ruzic, N Djokovic, T Djikic, K Nikolic Frontiers in Chemistry 7, 873, 2020 | 68 | 2020 |
| Modulating protein–protein interactions with visible‐light‐responsive peptide backbone photoswitches L Albert, A Peñalver, N Djokovic, L Werel, M Hoffarth, D Ruzic, J Xu, ... ChemBioChem 20 (11), 1417-1429, 2019 | 31 | 2019 |
| The oxidoreductase PYROXD1 uses NAD (P)+ as an antioxidant to sustain tRNA ligase activity in pre-tRNA splicing and unfolded protein response I Asanović, E Strandback, A Kroupova, D Pasajlic, A Meinhart, ... Molecular Cell 81 (12), 2520-2532. e16, 2021 | 15 | 2021 |
| Structure-based design of selective histone deacetylase 6 zinc binding groups LA Alves Avelar, D Ruzic, N Djokovic, T Kurz, K Nikolic Journal of Biomolecular Structure and Dynamics 38 (11), 3166-3177, 2020 | 9 | 2020 |
| Synthesis, in silico, and in vitro studies of novel dopamine D2 and D3 receptor ligands M Elek, N Djokovic, A Frank, S Oljacic, A Zivkovic, K Nikolic, H Stark Archiv der Pharmazie 354 (6), 2000486, 2021 | 8 | 2021 |
| Fragment-based drug design of selective HDAC6 inhibitors D Ruzic, N Djokovic, K Nikolic Protein-Ligand Interactions and Drug Design, 155-170, 2021 | 7 | 2021 |
| Bistable Photoswitch allows in vivo control of hematopoiesis L Albert, J Nagpal, W Steinchen, L Zhang, L Werel, N Djokovic, D Ruzic, ... ACS central science 8 (1), 57-66, 2021 | 6 | 2021 |
| An Integrative in silico Drug Repurposing Approach for Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease N Djokovic, D Ruzic, T Djikic, S Cvijic, J Ignjatovic, S Ibric, K Baralic, ... Molecular Informatics 40 (5), 2000187, 2021 | 6 | 2021 |
| Synthesis and biological activity of a cytostatic inhibitor of MLLr leukemia targeting the DOT1L protein C Bon, Y Si, M Pernak, M Barbachowska, E Levi-Acobas, V Cadet Daniel, ... Molecules 26 (17), 5300, 2021 | 5 | 2021 |
| Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket Dynamics N Djokovic, D Ruzic, M Rahnasto-Rilla, T Srdic-Rajic, ... Journal of Chemical Information and Modeling 62 (10), 2571-2585, 2022 | 4 | 2022 |
| Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation D Ruzic, B Ellinger, N Djokovic, JF Santibanez, S Gul, M Beljkas, A Djuric, ... Pharmaceutics 14 (12), 2600, 2022 | 2 | 2022 |
| Medicinal chemistry of histone deacetylase inhibitors D Ružić, N Đoković, K Nikolić, Z Vujić Arhiv za farmaciju 71 (2), 73-100, 2021 | 2 | 2021 |
| Reversible Control of RNA Splicing by Photoswitchable Small Molecules L Zhang, X Xie, N Djokovic, K Nikolic, D Kosenkov, F Abendroth, ... Journal of the American Chemical Society, 2023 | | 2023 |
| Correlating basal gene expression across chemical sensitivity data to screen for novel synergistic interactors of HDAC inhibitors in pancreatic carcinoma N Djokovic, A Djuric, D Ruzic, T Srdic-Rajic, K Nikolic Pharmaceuticals 16 (2), 294, 2023 | | 2023 |
| SIRT2i_Predictor: A machine learning-based tool to facilitate the discovery of novel SIRT2 inhibitors N Djokovic, M Rahnasto-Rilla, N Lougiakis, M Lahtela-Kakkonen, ... Pharmaceuticals 16 (1), 127, 2023 | | 2023 |
| Epigenetic drug discovery: fragment-based drug design of novel 1-benzhydryl-piperazine derivatives as selective histone deacetylase 6 inhibitors D Ružić, N Đoković, T Srdić-Rajić, K Nikolić Serbian Chemical Society and Serbian Young Chemists’ Club, Book of Abstracts, 15, 2022 | | 2022 |
| Discovery of 1-benzhydryl piperazine-based HDAC inhibitors with anti-cancer and anti-metastatic properties against human breast cancer: synthesis, molecular modeling, in vitro … D Ruzic, M Petkovic, N Djokovic, J Santibanez, B Ellinger, M Beljkas, ... | | 2022 |
| Computer-aided drug design and evaluation of selective inhibitors against cytoplasmic histone deacetylases D Ružić, N Đoković, M Petković, S Gul, M Lahtela‐Kakkonen, A Ganesan, ... 37th ACS National Medicinal Chemistry Symposium-American Chemical Society …, 2022 | | 2022 |
| Quinazoline-based analog of adenine as an antidote against MLL-rearranged leukemia cells: synthesis, inhibition assays and docking studies C Bon, M Barbachowska, N Djokovic, D Ruzic, Y Si, L Soresinetti, C Jallet, ... Future Medicinal Chemistry 14 (8), 557-570, 2022 | | 2022 |
| Rational design and in vitro evaluation of selective inhibitors of cytoplasmic histone deacetylases SIRT2 and HDAC6 D Ružić, N Đoković, M Petković, S Gul, M Lahtela‐Kakkonen, A Ganesan, ... EFMC-ISMC, XXVII EFMC International Symposium on Medicinal Chemistry, Book …, 2022 | | 2022 |
